301 related articles for article (PubMed ID: 24470514)
1. New strategies in lung cancer: translating immunotherapy into clinical practice.
Forde PM; Kelly RJ; Brahmer JR
Clin Cancer Res; 2014 Mar; 20(5):1067-73. PubMed ID: 24470514
[TBL] [Abstract][Full Text] [Related]
2. Advances in immunotherapy for non-small cell lung cancer.
Reckamp KL
Clin Adv Hematol Oncol; 2015 Dec; 13(12):847-53. PubMed ID: 27058851
[TBL] [Abstract][Full Text] [Related]
3. [Non-small cell lung cancer: news from immunotherapy].
Reinmuth N; Heigener DF; Reck M
Dtsch Med Wochenschr; 2015 Mar; 140(5):329-33. PubMed ID: 25734674
[TBL] [Abstract][Full Text] [Related]
4. Harnessing the immune system for the treatment of non-small-cell lung cancer.
Brahmer JR
J Clin Oncol; 2013 Mar; 31(8):1021-8. PubMed ID: 23401435
[TBL] [Abstract][Full Text] [Related]
5. Updates on immunotherapy in non-small cell lung cancer.
Shimanovsky A; Dasanu CA
Expert Opin Biol Ther; 2014 Apr; 14(4):411-8. PubMed ID: 24512518
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy: is a minor god yet in the pantheon of treatments for lung cancer?
Rolfo C; Sortino G; Smits E; Passiglia F; Bronte G; Castiglia M; Russo A; Santos ES; Janssens A; Pauwels P; Raez L
Expert Rev Anticancer Ther; 2014 Oct; 14(10):1173-87. PubMed ID: 25148289
[TBL] [Abstract][Full Text] [Related]
7. Exploring the potential of immuno-oncology-based treatment for patients with non-small cell lung cancer.
Heigener D; Reck M
Expert Rev Anticancer Ther; 2015 Jan; 15(1):69-83. PubMed ID: 25199617
[TBL] [Abstract][Full Text] [Related]
8. [Progress in Immunotherapy for Squamous Non-small Cell Lung Cancer].
Wang S; Li J
Zhongguo Fei Ai Za Zhi; 2016 Oct; 19(10):682-686. PubMed ID: 27760599
[TBL] [Abstract][Full Text] [Related]
9. Active immunotherapy for non-small-cell lung cancer: moving toward a reality.
Perez CA; Santos ES; Raez LE
Expert Rev Anticancer Ther; 2011 Oct; 11(10):1599-605. PubMed ID: 21999133
[TBL] [Abstract][Full Text] [Related]
10. Clinical Trials Integrating Immunotherapy and Radiation for Non-Small-Cell Lung Cancer.
Daly ME; Monjazeb AM; Kelly K
J Thorac Oncol; 2015 Dec; 10(12):1685-93. PubMed ID: 26484629
[TBL] [Abstract][Full Text] [Related]
11. Current clinical immunotherapy targets in advanced nonsmall cell lung cancer (NSCLC).
McCarthy F; Roshani R; Steele J; Hagemann T
J Leukoc Biol; 2013 Dec; 94(6):1201-6. PubMed ID: 23695306
[TBL] [Abstract][Full Text] [Related]
12. What lies within: novel strategies in immunotherapy for non-small cell lung cancer.
Forde PM; Reiss KA; Zeidan AM; Brahmer JR
Oncologist; 2013; 18(11):1203-13. PubMed ID: 24105749
[TBL] [Abstract][Full Text] [Related]
13. Cancer immunotherapy: a future paradigm shift in the treatment of non-small cell lung cancer.
Anagnostou VK; Brahmer JR
Clin Cancer Res; 2015 Mar; 21(5):976-84. PubMed ID: 25733707
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy for non-small cell lung cancer: novel approaches to improve patient outcome.
Shepherd FA; Douillard JY; Blumenschein GR
J Thorac Oncol; 2011 Oct; 6(10):1763-73. PubMed ID: 21876456
[TBL] [Abstract][Full Text] [Related]
15. Active specific immunotherapy and cell-transfer therapy for the treatment of non-small cell lung cancer.
Kakimi K; Nakajima J; Wada H
Lung Cancer; 2009 Jul; 65(1):1-8. PubMed ID: 19062127
[TBL] [Abstract][Full Text] [Related]
16. Advances in Immuno-Oncology: Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer-Introduction.
Socinski MA
Semin Oncol; 2015 Oct; 42 Suppl 2():S1-2. PubMed ID: 26477469
[No Abstract] [Full Text] [Related]
17. Current adoptive immunotherapy in non-small cell lung cancer and potential influence of therapy outcome.
Zheng YW; Li RM; Zhang XW; Ren XB
Cancer Invest; 2013 Mar; 31(3):197-205. PubMed ID: 23477587
[TBL] [Abstract][Full Text] [Related]
18. Beyond the standard of care: a review of novel immunotherapy trials for the treatment of lung cancer.
Hall RD; Gray JE; Chiappori AA
Cancer Control; 2013 Jan; 20(1):22-31. PubMed ID: 23302904
[TBL] [Abstract][Full Text] [Related]
19. Vaccines for the treatment of non-small cell lung cancer: a renewed anticancer strategy.
Gridelli C; Rossi A; Maione P; Ferrara ML; Castaldo V; Sacco PC
Oncologist; 2009 Sep; 14(9):909-20. PubMed ID: 19726457
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy for non-small cell lung cancer: are we on the cusp of a new era?
Waqar SN; Morgensztern D
Expert Rev Clin Immunol; 2015; 11(8):871-3. PubMed ID: 26051156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
